Position in TGTX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$904,202
+$444,837 QoQ
Shares Held
16,458
+19.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#196
of 423 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Portside Wealth Group, LLC holds $8,173,581 across 8 Biotechnology names. TGTX ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,258 | $2,611,805 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
4,810 | $1,520,392 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,159 | $1,346,222 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
This page
|
16,458 | $904,202 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
8,505 | $665,685 | |
| 6 | VCEL |
Vericel Corp
|
14,742 | $655,871 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
679 | $252,363 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
721 | $217,041 |
All Filings in TGTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $904,202 | 16,458 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $459,365 | 13,828 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $359,240 | 12,051 | Shares | Other | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||